, Volume 4, Issue 4, pp 387–398 | Cite as

Protective effect of trapencaine in acetic-acid-induced colitis in rats

  • V. Nosáĺová
  • V. Bauer
Cell Injury and Protection in the Gastrointestinal Tract: from Basic Science to Clinical Perspectives 8–11 October 1995, Pécs, Hungary


Despite extensive research, the aetiology and pathogenesis of ulcerative colitis are still unknown and the therapeutic approach remains therefore empirical. Since trapencaine, a local anaesthetic, has been repeatedly demonstrated to protect the gastric mucosa from the injurious effects of a variety of noxious stimuli, its efficacy against acute inflammatory attack of the colonic mucosa was studied in a rat model of colitis induced by intracolonic administration of 4% acetic acid.

Vehicle or trapencaine in doses of 3, 10 and 30 mg/kg were given 30 min before acetic acid and the resulting injury was assessed after 48 h. Gross findings were ranked using the criteria of MacPherson and Pfeiffer. The length and wet/dry weight ratio of the colon were recorded, colonic fluid absorption was assessed and myeloperoxidase activity in colonic mucosal scrapings was determined. Contractility of colonic muscle strips was examined in vitro.

Trapencaine pretreatment was found to reduce the extent of the inflammatory colonic mucosal injury induced by acetic acid administration, as evidenced by the significant decrease in the rank of gross mucosal damage and in wet/dry colonic weight ratio, as well as by the attenuation of granulocyte infiltration. The increased responsiveness of colonic smooth muscle to acetylcholine and barium chloride associated with acute colitis was diminished by trapencaine pretreatment. The results indicate that trapencaine locally present in the colon seems to maintain the intregrity of colonic mucosa.


acetic acid colitis rats trapencaine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roediger WEW, Nance S. Metabolic induction of experimental colitis by inhibition of fatty acid oxidation, Br J Exp Pathol. 1986;67:773–82.PubMedGoogle Scholar
  2. 2.
    Chester JF, Ross JS, Malt RA, Wietzman SA. Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol. 1985;121:284–90.PubMedGoogle Scholar
  3. 3.
    Grisham MB, Granger DN. Neutrophil-mediated mucosal injury, Dig Dis Sci. 1988;33(suppl):6S-15S.PubMedCrossRefGoogle Scholar
  4. 4.
    Koo A, Leung FW. Microcirculation of the colon: macromolecular permeability and loss of the endothelial viability in experimental colitis in rats. Prog Appl Microcirc. 1990;17:90–100.Google Scholar
  5. 5.
    Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology. 1985;8:55–63.Google Scholar
  6. 6.
    Björck S, Dahlström A, Johansson L, Ahlman H. Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions. 1992;Special Conference Issue:C60–72.Google Scholar
  7. 7.
    Björck S, Dahlström A, Ahlman H. Topical treatment of ulcerative proctitis with lidocaine. Scand J Gastroenterol. 1989;24:1061.PubMedGoogle Scholar
  8. 8.
    Beneš L, Borovanský A, Kopáčová L. Alkoxycarbanilic acid esters with high local anaesthetic activity. Arzneim.-Forsch (Drug Res). 1969;19:1902.Google Scholar
  9. 9.
    Beneš L. Trapencaine hydrochloride. Drugs Future. 1991;16:627–30.Google Scholar
  10. 10.
    Nosáĺová V, Babuĺová A, Beneš L. On gastric cytoprotective effect of pentacaine. Acta Pharmacol Toxicol. 1986;59(suppl):201.Google Scholar
  11. 11.
    Nosáĺová V, Babuĺová A, Jakubovský J, Beneš L. Experimental peptic ulcer: effect of pentacaine. In: Szabo S, Mozsik Gy, eds. New Pharmacology of Ulcer Disease. New York: Elsevier; 1987: 505–16.Google Scholar
  12. 12.
    Eliakim R, Karmeli F, Okon E, Rachmilewîtz D. Ketotifen effectively prevents mucosal damage i experimental colitis. Gut. 1992;33:1498–503.PubMedCrossRefGoogle Scholar
  13. 13.
    Fedorak RN, Empey LR, MacArthur C, Jewell LD. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 1990;98:615–25.PubMedGoogle Scholar
  14. 14.
    MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion. 1978;17:135–50.PubMedGoogle Scholar
  15. 15.
    Fedorak RN, Empey LR, Walker K. Verapamil alters eicosanoid synthesis and accelerates healing during experimental colitis in rats. Gastroenterology. 1992;102:1229–35.PubMedGoogle Scholar
  16. 16.
    Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Noronha-Blob L, Lowe VC, Muhlhauser RO, Burch RM. NPC 15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology. 1993;104:1021–9.PubMedGoogle Scholar
  18. 18.
    Goldstein IM, Lind S, Hoffstein S, Weissman G. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and superoxide anion production. J Exp Med. 1977;146:483–94.PubMedCrossRefGoogle Scholar
  19. 19.
    MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood. 1980;56:203–9.PubMedGoogle Scholar
  20. 20.
    Nosáĺová V, Babulová A. Gastric antiulcer activity of pentacaine: possible mechanism of action. Physiol Res. 1994;43:181–6.Google Scholar
  21. 21.
    McCafferty D-M, Sharkey KA, Wallace JL. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol. 1994;266:G560–7.PubMedGoogle Scholar
  22. 22.
    Štolc S, Stankovičová T. Effect of local anaesthetics and pH: new aspects. Drugs Exp Clin Res. 1986;12:753–60.PubMedGoogle Scholar
  23. 23.
    Yamada T, Specian RD, Granger DN, Gaginella TS, Grisham MB. Misoprostol attenuates acetic acid-induced increases in mucosal permeability and inflammation: role of blood flow. Am J Physiol. 1991;261:G332–9.PubMedGoogle Scholar
  24. 24.
    Ebashi S, Endo M. Calcium ion and muscle contraction. Progr Biophys Mol Biol. 1968;18:123–83.CrossRefGoogle Scholar
  25. 25.
    Benham CD, Bolton TB, Lang RJ, Takewaki T. The mechanism of action of Ba2+ and TEA on single Ca2+-activated K+-channels in arterial and intestinal smooth muscle cell membranes. Pflugers Arch. 1985;403:120–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Feinstein MB, Paimre M. Pharmacological action of local anesthetics on excitation-contraction coupling in striated and smooth muscle. Fed Proc. 1969;28:1643–8.PubMedGoogle Scholar
  27. 27.
    Vermillion DL, Collins SM. Increased responsiveness of jejunal longitudinal muscle in Trichenella-infected rats. Am J Physiol. 1988;254:G124–9.PubMedGoogle Scholar
  28. 28.
    Cohen JD, Kao HW, Tan ST, Lechago J, Snape WJ Jr. Effect of acute experimental colitis on rabbit colonic smooth muscle. Am J Physiol. 1986;251:G538–45.PubMedGoogle Scholar
  29. 29.
    Percy WH, Burton MB, Jacobowitz Y, Burakof R. An investigation in vitro of the properties of the individual muscle layers of the rabbit colon in an induced colitis. In: Snape WJ, Collins SM, eds. Effect of immune cells and inflammation on smooth muscle and enteric nerves. Boca Raton: C.R.C.; 1991;95–108.Google Scholar
  30. 30.
    Grossi L, McHugh K, Collins SM. On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology. 1993;104:1049–56.PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag AG 1996

Authors and Affiliations

  • V. Nosáĺová
    • 1
  • V. Bauer
    • 1
  1. 1.Institute of Experimental PharmacologySlovak Academy of SciencesBratislavaSlovak Republic

Personalised recommendations